Conference Proceedings

Disparities starting adjuvant chemotherapy for locally advanced cervix cancer in the international, academic, randomised, phase III OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274)

L Mileshkin, E Barnes, KN Moore, V Gebski, M King, K Narayan, IK Kolodziej, K Sjoquist, A Fyles, W Small, D Gaffney, M Quinn, J Andrews, S Thompson, W Huh, M Carlson, PA Disilvestro, D Rischin, MR Stockler, BJ Monk

ANNALS OF ONCOLOGY | OXFORD UNIV PRESS | Published : 2019

Grants

Funding Acknowledgements

National Health and Medical Research Council. In addition, Hospira provided paclitaxel treatment for Australian and New Zealand patients in the study.